Pharma gifts to doctors persist despite scrutiny; debate continues

Despite ongoing controversy over doctors accepting gifts and speaking fees from pharmaceutical companies, new reporting indicates such practices continue unabated. The article suggests that while the debate is rancorous, physicians have not changed their behavior, highlighting a persistent ethical and regulatory gap. This matters as it underscores the resilience of industry-physician financial ties amid public and policy pressure.